Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials | Circulation

2022-12-01 08:32:14 By : Mr. Morton Wang

This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies.

Click here for more information. Nitrilase

Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials | Circulation

https://orcid.org/0000-0003-4395-6742

Department of Advanced Biomedical Sciences, University Federico II of Naples, Italy (G.G., G.E.).

Search for more papers by this author

https://orcid.org/0000-0001-9008-3011

Cardiology Department, Alto Vicentino Hospital, Santorso, Italy (DG).

Cardiovascular Research Institute, Mater Private Hospital, Royal College of Surgeons in Ireland, Dublin (D.G.).

ISA Research Center, German Heart Center Munich, Technical University of Munich, Germany (DG).

Search for more papers by this author

https://orcid.org/0000-0003-2329-2504

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Canada (S.S.J., S.R.M.).

Search for more papers by this author

https://orcid.org/0000-0001-8875-8841

University of British Columbia, Vancouver, Canada (J.C.).

Search for more papers by this author

https://orcid.org/0000-0002-4643-1709

Department of Medicine, University of Ottawa Heart Institute, Canada (M.L.M., G.A.W.).

Search for more papers by this author

https://orcid.org/0000-0003-3142-7667

University Hospital and Faculty of Medicine Pilsen, Charles University, Czech Republic (I.B.).

Search for more papers by this author

https://orcid.org/0000-0003-1611-7708

Agostino Gemelli University Hospital Foundation, IRCCS, Rome, Italy (ER).

Search for more papers by this author

https://orcid.org/0000-0003-2914-0894

The Duke Clinical Research Institute, Durham, NC (S.V.R.).

Search for more papers by this author

https://orcid.org/0000-0002-9609-3728

Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands (M.A.H.v.L., T.A.M.).

Search for more papers by this author

https://orcid.org/0000-0003-3258-949X

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Canada (S.S.J., S.R.M.).

Search for more papers by this author

Quebec Heart and Lung Institute, Quebec City, Canada (O.F.B.).

Search for more papers by this author

Department of Medicine, University of Ottawa Heart Institute, Canada (M.L.M., G.A.W.).

Search for more papers by this author

https://orcid.org/0000-0002-4298-1607

Department of Cardiology, Isala Heart Center, Zwolle, The Netherlands (M.A.H.v.L., T.A.M.).

Search for more papers by this author

https://orcid.org/0000-0003-2128-9205

Department of Cardiology, University Hospital of Bern, Switzerland (G.C.M.S., S.W., M.V.).

Search for more papers by this author

https://orcid.org/0000-0003-0565-7127

Department of Advanced Biomedical Sciences, University Federico II of Naples, Italy (G.G., G.E.).

Search for more papers by this author

https://orcid.org/0000-0003-2653-6762

Department of Cardiology, University Hospital of Bern, Switzerland (G.C.M.S., S.W., M.V.).

Search for more papers by this author

https://orcid.org/0000-0002-5985-0670

Applied Health Research Center, Li Ka Shing Knowledge Institute, St Michael’s Hospital, and Department of Medicine, University of Toronto, Canada (P.J.).

Search for more papers by this author

Correspondence to: Marco Valgimigli, MD, PhD, Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete, 48, CH-6900, University of Italian Switzerland (USI), Lugano, Switzerland.E-mail

Department of Cardiology, University Hospital of Bern, Switzerland (G.C.M.S., S.W., M.V.).

Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland (MV).

Search for more papers by this author

Search for more papers by this author

In some randomized clinical trials, transradial access (TRA) compared with transfemoral access (TFA) was associated with lower mortality in patients with coronary artery disease undergoing invasive management. We analyzed the effects of TRA versus TFA across multicenter randomized clinical trials and whether these associations are modified by patient or procedural characteristics.

We performed an individual patient data meta-analysis of multicenter randomized clinical trials comparing TRA with TFA among patients undergoing coronary angiography with or without percutaneous coronary intervention. The primary outcome was all-cause mortality and the co–primary outcome was major bleeding at 30 days. The primary analysis was conducted by 1-stage mixed-effects models on the basis of the intention-to-treat cohort. The effect of access site on mortality and major bleeding was assessed further by multivariable analysis. The relationship among access site, bleeding, and mortality was investigated by natural effect model mediation analysis with multivariable adjustment.

A total of 21 600 patients (10 775 TRA, 10 825 TFA) from 7 randomized clinical trials were included. The median age was 63.9 years, 31.9% were women, 95% presented with acute coronary syndrome, and 75.2% underwent percutaneous coronary intervention. All-cause mortality (1.6% versus 2.1%; hazard ratio, 0.77 [95% CI, 0.63–0.95]; P=0.012) and major bleeding (1.5% versus 2.7%; odds ratio, 0.55 [95% CI, 0.45–0.67]; P<0.001) were lower with TRA. Subgroup analyses for mortality showed consistent results, except for baseline hemoglobin level (Pinteraction=0.003), indicating that the benefit of TRA was substantial in patients with moderate or severe anemia, whereas it was not significant in patients with milder or no baseline anemia. After adjustment, TRA remained associated with 24% and 51% relative risk reduction of all-cause mortality and major bleeding, respectively. A mediation analysis showed that the benefit of TRA on mortality was only partially driven by major bleeding prevention and ancillary mechanisms are required to fully explain the causal association.

TRA is associated with lower all-cause mortality and major bleeding at 30 days compared with TFA. The effect on mortality was driven by patients with anemia. The reduction in major bleeding only partially explains the mortality benefit.

URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42018109664.

*G. Gargiulo and D. Giacoppo contributed equally.

Circulation is available at www.ahajournals.org/journal/circ

This work was presented as an abstract at the ESC Congress, August 26-29, 2022, in Barcelona, Spain.

Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/CIRCULATIONAHA.122.061527.

For Sources of Funding and Disclosures, see page 1342.

Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials | Circulation

Lo Supplier National Center 7272 Greenville Ave. Dallas, TX 75231 Customer Service 1-800-AHA-USA-1 1-800-242-8721 Local Info Contact Us